Aminex Therapeutics, Inc.

CIK 1613386 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aminex Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Dec 5, 2025D0001470831-25-000383
Aug 19, 2021D0001613386-21-000001
Aug 14, 2020D0001613386-20-000001
Jun 1, 2018D0001613386-18-000001
Nov 12, 2014D0001613386-14-000002
Jul 11, 2014D0001613386-14-000001